'LabCorp at Walgreens' brings testing to the patient's corner drugstore

By Melissa Fassbender contact

- Last updated on GMT

“LabCorp at Walgreens” sites will provide specimen collection services for LabCorp testing. (Image: iStock/RiverNorthPhotography)
“LabCorp at Walgreens” sites will provide specimen collection services for LabCorp testing. (Image: iStock/RiverNorthPhotography)

Related tags: Clinical trial, Patient

LabCorp has teamed up with Walgreens to open “LabCorp at Walgreens” service centers and will explore additional collaboration opportunities – such as in clinical trial enrollment. 

As part of the collaboration, LabCorp will develop and operate patient service centers within select Walgreens stores. Seven locations will begin seeing patients in 2017.

If successful, the clinical laboratory service provider hopes to roll out similar centers more broadly, David P. King, LabCorp’s chairman and CEO told Oursoucing-Pharma.com.

King said the company has been interested in a retail strategy for some time and after talking to a number of potential partners, LabCorp felt Walgreens was the best suited, he explained.

What we’ve done is created a convenient place where patients can fill their needs after or before a physician visit​,” said King – and it’s also extended its brand into a new, more direct consumer engaged channel, which he said is a key initiative for the company.

According to King, more than 100,000 patients have consented to be candidates for clinical trials if their condition diagnoses are a potential fit for clinical trials, which its Covance Drug Development business may end up running

So again, direct engagement with the patient at Walgreens … even seeing our site at the Walgreens​” will help raise awareness, he said, noting that everything the company can do to get closer to the consumer supports the idea that it can create a bigger database of eligible candidate for trials.

Over time we’d love to explore other ways to collaborate with Walgreens around things like trial enrollment​,” said King. “There are other ways that we see the potential for this to expand if the concept proves successful​.”

Related topics: Markets & Regulations, Phase III-IV

Related news

Show more

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 01-Nov-2021 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars